Opendata, web and dolomites

SUDOCHIP

New antiperspirant efficacy evaluation techniques based on a disruptive microfluidic technology

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SUDOCHIP project word cloud

Explore the words cloud of the SUDOCHIP project. It provides you a very rough idea of what is the project "SUDOCHIP" about.

regulates    market    skin    artificial    87    suppliers    first    ap    raw    paradigm    aps    leaders    exempt    explore    marketing    faster    groups    food    measured    mimics    human    twenty    requesting    direct    hot    efforts    protocol    reproducible    room    axillae    dominate    volunteers    drug    prototype    aluminium    finalise    precisely    10k    world    prioritise    smes    considerable    techniques    ingredients    2023    efficacy    time    unadapted    microfluidic    cancer    formulations    36    sweating    2015    expensive    phase1    technique    predefined    industry    sales    almost    gold    unreliable    instrument    create    hundred    fear    countries    20bn    adults    business    changed    gravimetry    otherwise    jobs    administration    turnover    generate    natural    reduce    road    performed    armpit    microfactory    standard    free    validation    accelerate    drive    global    international    consuming    40    million    carcinogenic    components    validated    few    antiperspirants    commercial    cheaper    successfully    minutes    last    invented    vivo    cosmetic    sweat    perfectly    subjects   

Project "SUDOCHIP" data sheet

The following table provides information about the project.

Coordinator
MICROFACTORY 

Organization address
address: 10 RUE VAUQUELIN
city: PARIS
postcode: n.a.
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Project website http://www.microfactory.eu
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.5. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced manufacturing and processing)
2. H2020-EU.2.1.3. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials)
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-08-01   to  2018-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MICROFACTORY FR (PARIS) coordinator 50˙000.00

Map

 Project objective

Antiperspirants (APs) are among the most widely used cosmetic products that reduce sweat in the axillae (€20bn market in 2015). They are used by almost 90 % of the adults in developed countries. The Food and Drug Administration regulates APs, and gravimetry is the gold standard technique used to test them. More precisely, a direct application of the test sample on the armpit is performed on 40 volunteers and sweating is measured under predefined conditions in a hot room. This technique, which has not changed for the last twenty years, is time-consuming (a month), expensive (up to 10K€), and unreliable (/- 40%). Due to consumer fear that aluminium in APs may cause cancer, aluminium-free, “natural” APs will dominate the market. A change of paradigm is down the road, requesting the design and test of a considerable number of new formulations, for which the existing methods are clearly unadapted. Microfactory has invented a new microfluidic instrument and AP efficacy testing protocol using natural or artificial sweat that perfectly mimics the in vivo skin sweating process. The test does not require human subjects, is one hundred time faster (few minutes), is cheaper than other techniques, and is highly reproducible. The first prototype has been successfully validated by two world leaders in the cosmetic industry. It will accelerate the design of new antiperspirants with more natural ingredients exempt of carcinogenic components, that would otherwise take many years to develop using the current techniques. The Phase1 objective is to finalise instrument validation over a new range of aluminium free commercial APs and to explore and prioritise new market applications. For Microfactory, it will open new global business opportunities with major international cosmetic groups, SMEs and suppliers of raw cosmetic ingredients. It will generate an ambitious turnover of €36 million in 2023, as well as create 87 new European jobs to drive development, marketing and sales efforts.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SUDOCHIP" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SUDOCHIP" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.5.;H2020-EU.2.1.3.;H2020-EU.2.3.1.;H2020-EU.2.1.2.)

NAS (2018)

Nexilis augmentation system

Read More  

SUPPLEPRINT (2018)

Super Productive Line Printing Inkjet

Read More  

STAR (2018)

Safe, Transparent, Active and Reliable mineral sunscreen technology

Read More